Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

4.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

14.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

6.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

10.1K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

mTOR Substrate Phosphorylation in Growth Control: An Update.

Cancers·2026
Same author

Multi-omics profiling reveals divergent biology and liver microenvironment in HCC of metastatic and de novo origin.

Molecular cancer·2026
Same author

Acid Versus Amide-Facts and Fallacies: A Case Study in Glycomimetic Ligand Design.

Molecules (Basel, Switzerland)·2025
Same author

Identification of transglutaminase 2 mediated polyaminated proteins in a hepatocellular cancer cell line.

Computational and structural biotechnology journal·2025
Same author

A multichaperone condensate enhances protein folding in the endoplasmic reticulum.

Nature cell biology·2025
Same author

Architecture and conformational dynamics of the BAM-SurA holo insertase complex.

Science advances·2025

Related Experiment Video

Updated: Sep 23, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.2K

mTOR substrate phosphorylation in growth control.

Stefania Battaglioni1, Don Benjamin1, Matthias Wälchli1

  • 1Biozentrum, University of Basel, Spitalstrasse 41, 4056 Basel, Switzerland.

Cell
|May 17, 2022
PubMed
Summary
This summary is machine-generated.

The target of rapamycin (TOR) kinase regulates cell growth and metabolism. Mammalian TOR complexes mTORC1 and mTORC2 phosphorylate distinct substrates using a common motif, despite sharing a catalytic subunit.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

287
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.8K

Related Experiment Videos

Last Updated: Sep 23, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

287
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.8K

Area of Science:

  • Molecular Biology
  • Cellular Metabolism
  • Biochemistry

Background:

  • The target of rapamycin (TOR) is a crucial serine/threonine kinase regulating cell growth and metabolism.
  • TOR signaling is activated by nutrients, growth factors, and cellular energy levels.
  • TOR exists in two distinct complexes, TORC1 and TORC2, with differing functions.

Purpose of the Study:

  • To review and identify all direct substrates of mammalian TOR (mTOR).
  • To elucidate how mTORC1 and mTORC2 phosphorylate distinct substrates.
  • To understand the substrate recruitment mechanism by mTOR complexes based on structural data.

Main Methods:

  • Comprehensive literature review of mTOR signaling.
  • Identification of direct mTOR substrates.
  • Analysis of structural information regarding mTOR complexes.

Main Results:

  • Identified numerous direct substrates for mTOR.
  • Demonstrated that mTORC1 and mTORC2 phosphorylate distinct sets of substrates.
  • Showed that both complexes utilize a common phosphorylation motif.

Conclusions:

  • mTORC1 and mTORC2, despite a shared catalytic subunit, exhibit substrate specificity.
  • The two complexes recruit different substrates through distinct mechanisms.
  • A common minimal motif is phosphorylated by both mTOR complexes, indicating coordinated regulation.